Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-Intron vs. Interferon Alfa-2B in Treatment-Naïve Chronic Hepatitis C
NCT03537274Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 1997
- Primary completion
- Jul 1999
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
01
Overview
A Phase 3 trial of peginterferon alfa-2b in hepatitis C (HCV), sponsored by Merck & Co.. Started Aug 1997; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03537274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03537274.